225Ac-labeled anti-EGFR antibody drug radioconjugate elicits durable anti-tumor responses in mouse models of colorectal cancer

被引:0
|
作者
Tikum, F. [1 ]
Henning, N. [1 ]
Doroudi, A. [1 ]
Ketchemen, J. [1 ]
Babeker, H. [1 ]
Njotu, F. [1 ]
Monzer, A. [1 ]
Nwangele, E. [1 ]
Uppalapati, M. [1 ]
Gray, B. [1 ]
Torlakovic, E. [1 ]
Fonge, H. [1 ]
机构
[1] Univ Saskatchewan, Saskatoon, SK, Canada
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-674
引用
收藏
页码:S321 / S322
页数:2
相关论文
共 50 条
  • [21] Novel antibody-drug conjugates targeting Axl show anti-tumor activity in solid cancer xenograft models
    Breij, Esther C. W.
    Verploegen, Sandra
    Lingnau, Andreas
    van den Brink, Edward N.
    Janmaat, Maarten
    Houtkamp, Mischa
    Bleeker, Wim K.
    Satijn, David
    Parren, Paul W. H. I.
    CANCER RESEARCH, 2015, 75
  • [22] Triplet-drug chemotherapy combined with anti-EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis
    Tian, Muyou
    Li, Huifen
    Dong, Wenjing
    Li, Yuhong
    Jiang, Ting
    Lv, Yanhua
    Zeng, Jianxiong
    Jiang, Xiaomei
    Yin, Zhaofeng
    Xiao, Jianjun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [23] A novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5 has potent anti-tumor activity in colorectal cancer models
    Baudat, Yves
    Neff-LaFord, Haley
    Nicolazzi, Celine
    Meyer, Dave
    Sigurjonsson, Johann Petur
    Lyski, Ryan
    Fantin, Valeria
    Brun, Marie-Priscille
    Chiron, Marielle
    Decary, Stephanie
    CANCER RESEARCH, 2023, 83 (07)
  • [24] LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions
    Surguladze, David
    Pennello, Anthony
    Ren, Xiaodi
    Mack, Tim
    Rigby, Alan
    Balderes, Paul
    Navarro, Elizabeth
    Amaladas, Nelusha
    Eastman, Scott
    Topper, Michael
    Yao, Yung-Mae
    Moxham, Chris
    Plowman, Gregory
    Ludwig, Dale
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Role of MEK inhibition in improving anti-tumor responses in xenograft models of BRAF-mutated metastatic colorectal cancer.
    Morris, Van Karlyle
    Wu, Ji
    Adam, Liana
    Tian, Feng
    Gagea, Mihai
    Hong, David S.
    Menter, David
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [26] ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
    Kang, Han Na
    Kim, Se-Ho
    Yun, Mi Ran
    Kim, Hye Ryun
    Lim, Sun Min
    Kim, Min-Soo
    Hong, Kwang-Won
    Kim, Sung-Moo
    Kim, Hwan
    Pyo, Kyoung-Ho
    Park, Hye Ji
    Han, Joo Yeun
    Youn, Hyun A.
    Chang, Ki-Hwan
    Cho, Byoung Chul
    LUNG CANCER, 2016, 95 : 57 - 64
  • [27] ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2015, 26 : 38 - 38
  • [28] Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models
    Kandaswamy, Veena
    Forest, Amelie
    Deroose, Marianne
    Schaer, David A.
    Chen, Ting
    Liu, Shengwu
    Surguladze, David
    Yao, Yung-mae
    Doman, Thompson
    Hall, Gerald
    Wong, Kwok-Kin
    Kalos, Michael
    Novosiadly, Ruslan D.
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Efficacy and safety of novel [225Ac]Ac-labeled anti-HER2 antibody drug radioconjugates against HER2 positive breast cancer xenografts
    Ketchemen, J. Pougoue
    Monzar, A.
    Njotu, F. Ngoh
    Babeker, H.
    Tikum, A.
    Nwangele, E.
    Henning, N.
    Hassani, N.
    Doroudi, A.
    Fonge, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S42 - S42
  • [30] Anti-tumor effect of an anti-human mullerian inhibiting substance type II receptor antibody in mouse models for ovarian cancer: towards a new targeted therapy
    Kersual, Nathalie A.
    Garambois, Veronique
    Salhi, Imed
    Chardes, Thierry
    Colombo, Pierre Emmanuel
    Bascoul-Mollevi, Caroline
    Cambon-Roques, Sylvie
    Bibeau, Frederic
    Pouget, Jean Pierre
    Behrens, Christian
    Gaucher, Christine
    Urbain, Remy
    Prose, Jean Frangois
    Pelegrin, Andre
    Navarro-Teulon, Isabelle
    CANCER RESEARCH, 2011, 71